GT Biopharma, Inc. — All Filings
857 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-C
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFR14A
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRER14C
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | — | 0001493152-25-010276 | Mar 14, 2025 | — |
| EFFECT | — | 9999999995-25-000665 | Mar 13, 2025 | — |
| CORRESP | — | 0001493152-25-009853 | Mar 11, 2025 | — |
| UPLOAD | — | 0000000000-25-002658 | Mar 11, 2025 | — |
| D | — | 0000109657-25-000002 | Mar 7, 2025 | — |
| S-3 | — | 0001493152-25-009422 | Mar 6, 2025 | — |
| 8-K | — | 0001493152-25-008387 | Feb 26, 2025 | Feb 25, 2025 |
| RW | — | 0001493152-25-007976 | Feb 24, 2025 | — |
| 10-K | — | 0001493152-25-007908 | Feb 21, 2025 | Dec 31, 2024 |
| S-1/A | — | 0001493152-25-005314 | Feb 7, 2025 | — |
| 8-K | — | 0001493152-25-003707 | Jan 27, 2025 | — |
| S-1/A | — | 0001493152-25-003718 | Jan 27, 2025 | — |
| S-1 | — | 0001493152-24-051873 | Dec 23, 2024 | — |
| 8-K | — | 0001493152-24-047994 | Nov 27, 2024 | Nov 21, 2024 |
| 8-K | — | 0001493152-24-047085 | Nov 21, 2024 | Nov 18, 2024 |
| 10-Q | — | 0001493152-24-045892 | Nov 14, 2024 | Sep 30, 2024 |
| 4 | — | 0001493152-24-041855 | Oct 21, 2024 | Oct 17, 2024 |
| SCHEDULE 13G/A | — | 0001042167-24-000067 | Oct 17, 2024 | — |
| 8-K | — | 0001493152-24-036381 | Sep 16, 2024 | — |
| 10-Q | — | 0001493152-24-032143 | Aug 14, 2024 | Jun 30, 2024 |
| 424B3 | — | 0001493152-24-026034 | Jul 2, 2024 | — |
| EFFECT | — | 9999999995-24-002019 | Jun 28, 2024 | — |
| S-1/A | — | 0001493152-24-025390 | Jun 27, 2024 | — |
| CORRESP | — | 0001493152-24-025392 | Jun 27, 2024 | — |
| 8-K | — | 0001493152-24-025382 | Jun 27, 2024 | — |
| 8-K | — | 0001493152-24-025269 | Jun 26, 2024 | Jun 25, 2024 |
| UPLOAD | — | 0000000000-24-007140 | Jun 24, 2024 | — |
| S-1 | — | 0001493152-24-024367 | Jun 20, 2024 | — |
| DEFA14A | — | 0001493152-24-024128 | Jun 17, 2024 | — |
| 3 | — | 0001493152-24-023692 | Jun 13, 2024 | Jun 3, 2024 |
| 8-K | — | 0001493152-24-023195 | Jun 7, 2024 | Jun 3, 2024 |
| 8-K | — | 0001493152-24-021078 | May 23, 2024 | May 21, 2024 |
| 424B5 | — | 0001493152-24-021081 | May 23, 2024 | — |
| SC 13G/A | AMENDMENT NO. 17 TO SCHEDULE 13G | 0001683168-24-003805 | May 23, 2024 | — |
| 10-Q | — | 0001493152-24-019970 | May 15, 2024 | Mar 31, 2024 |
| 8-K | — | 0001493152-24-017209 | Apr 30, 2024 | Apr 25, 2024 |
| ARS | — | 0001493152-24-016976 | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | — | 0001493152-24-016962 | Apr 29, 2024 | — |
| DEF 14A | — | 0001493152-24-016949 | Apr 29, 2024 | — |
| 10-K | — | 0001493152-24-011332 | Mar 26, 2024 | Dec 31, 2023 |
| SC 13G/A | — | 0001172661-24-001266 | Feb 14, 2024 | — |
| 8-K | — | 0001493152-24-004587 | Feb 1, 2024 | — |
| 8-K | — | 0001493152-23-045714 | Dec 21, 2023 | Dec 18, 2023 |
| 8-K | — | 0001493152-23-043582 | Dec 4, 2023 | — |
| DEFA14A | — | 0001493152-23-039586 | Nov 6, 2023 | — |
| DEF 14A | — | 0001493152-23-039585 | Nov 6, 2023 | — |
| DEFA14A | — | 0001493152-23-039588 | Nov 6, 2023 | — |
| 10-Q | — | 0001493152-23-038957 | Nov 1, 2023 | Sep 30, 2023 |
| PRE 14A | — | 0001493152-23-038560 | Oct 27, 2023 | — |
| SC 13G | SCHEDULE 13G | 0001042167-23-000059 | Sep 19, 2023 | — |